Also see: Dendreon, Tiffany: Analysts' New Ratings
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (TheStreet) -- STOCK COMMENTS / EPS CHANGES
Agrium (AGU) estimates, target raised at UBS. Shares of AGU now seen reaching $115. Estimates also raised on improving gross margins in all three strategic business units. Buy rating.Arcos Dorados (ARCO) estimates, target increased at Citigroup. Shares of ARCO now seen reaching $32. Estimates also raised on NOLAD turnaround and margin boosts. Buy rating. Atmel (ATML) estimates, target lowered at UBS. Shares of ATML now seen reaching $18. Estimates also lowered as weaker macro slows growth. Buy rating. Activision Blizzard (ATVI) estimates higher at UBS. TVI estimates were raised through 2012. New digital business models enhance margin, drive growth. Maintain $14 price target and Buy rating. Bruker (BRKR) estimates, target lowered at UBS. Shares of BRKR now seen reaching $21. Estimates also lowered on higher SG&A costs. Buy rating. Cott (COT) estimates lowered at UBS through 2011. Gross margins decline amid higher commodity costs. Maintain $10 price target and Buy rating. Cisco (CSCO) target lowered at Citigroup to $17.50. Restructuring and macro headwinds weight on NT outlook. Hold rating. Duke Energy (DUK) numbers boosted at Credit Suisse. Shares of DUK now seen reaching $19. Estimates also upped, to match the company's new guidance. Neutral rating. DaVita estimates raised at UBS through 2012. Solid guidance and lower EPO/better Medicare rate. Maintain $100 price target and Buy rating. Emerson (EMR) estimates, target cut at Credit Suisse. EMR estimates were reduced through 2013. Company is leveraged to lower macroeconomic growth. Outperform rating and new $59 price target. Genpact (G) estimates, target increased at Citigroup. Shares of G now seen reaching $18. Estimates also raised on strong 2Q. Hold rating. Hewlett-Packard (HPQ) numbers reduced at Barclays. Shares of HPQ now seen reaching $37. Estimates also cut, given lower PC demand. Equal-weight rating. IntercontinentalExchange (ICE) numbers cut at Barclays. Shares of ICE now seen reaching $148. Estimates also lowered, given the company's new volume forecast. Overweight rating. ICE estimates, target lowered at UBS. Shares of ICE now seen reaching $140, according to UBS. Estimates also lowered on updated volume assumptions. Buy rating.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV